RBP4 and coronary artery disorder: Furthermore, this study revealsthat the adipokine RBP4 is an independent risk factor for coronary arteryelasticity and shows differences in levels between CHD patients with and withoutT2DM, providing a new therapeutic strategy for patients with CHD combined withT2DM.